Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

NCT00709371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

729

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Zonisamide SR placebo/ bupropion SR placebo
DRUG: Zonisamide SR placebo/ bupropion SR 360 mg/day
DRUG: Zonisamide SR 120 mg/day/ bupropion SR placebo
DRUG: Zonisamide SR 360 mg/day/ bupropion SR placebo
DRUG: Zonisamide SR 120 mg/day/ bupropion SR 360 mg/day
DRUG: Zonisamide SR 360 mg/day/ bupropion SR 360 mg/day

Sponsor

Orexigen Therapeutics, Inc